- Risk Factors in first presentation acute coronary syndromes (ACS): how do we move from population to individualized risk prediction?
Department of Cardiovascular Medicine, Tufts University School of Medicine, Bay State Medical Center, Springfield, Massachusetts 01109, USA
Angiology 60:663-7. 2009
..Current population-based screening efforts must be improved to allow more effective prevention strategies and more individualized risk prediction...
- Can an elderly woman's heart be too strong? Increased mortality with high versus normal ejection fraction after an acute coronary syndrome. The Global Registry of Acute Coronary Events
Fadi A Saab
Department of Internal Medicine, Tufts University School of Medicine Baystate Medical Center, Springfield, MA, USA
Am Heart J 160:849-54. 2010
- Impact of duty hours restrictions on quality of care and clinical outcomes
Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA
Am J Med 120:968-74. 2007
..The objective of this study was to assess the impact of the duty-hours restrictions on quality of care and outcomes of patients with acute coronary syndrome...
- A prior myocardial infarction: how does it affect management and outcomes in recurrent acute coronary syndromes?
Apurva A Motivala
Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan 48109 0477, USA
Clin Cardiol 31:590-6. 2008
..The differences in presentation, management, and subsequent clinical outcomes in patients with and without a prior myocardial infarction (MI) and presenting with another episode of ACS remain unexplored...
- Ascending aortic pseudoaneurysm, a ticking bomb after cardiac surgery
Cardiovascular Division, Department of Medicine, Baystate Medical Center Tufts University School of Medicine, Springfield, MA 01199, USA
Cardiovasc Revasc Med 12:177-80. 2011
..Surgical intervention was successful and she was discharged home without significant issues...
- Bleeding risk and safety profile related to the use of eptifibatide: a current review
Tufts University School of Medicine, Baystate Medical Center, Department of Internal Medicine, Cardiovascular Medicine, Springfield, MA 01199, USA
Expert Opin Drug Saf 11:315-24. 2012
..Eptifibatide is a glycoprotein IIb/IIIa inhibitor that blocks the final common pathway of platelet aggregation. Its major adverse effect is bleeding. Balancing its safety and efficacy is paramount for its appropriate usage...
- Takayasu arteritis in a young woman: a 4-year case history
Division of Cardiology, Baystate Medical Center Tufts University School of Medicine, Springfield, Massachusetts 01199, USA
Tex Heart Inst J 36:470-4. 2009
..We discuss the challenges of managing Takayasu arteritis in our patient and describe different treatments for this rare vasculitic disorder...